Chinese Journal of Tissue Engineering Research ›› 2010, Vol. 14 ›› Issue (10): 1874-1877.doi: 10.3969/j.issn.1673-8225.2010.10.035

Previous Articles     Next Articles

Umbilical cord blood and blood plasma infusion for treating hepatitis: Grouping control and 1-year follow-up

Chen Li-min1, Tang Xiao-peng2, Gong Huan-yu1   

  1. 1Department of Infection Diseases, Third Xiangya Hospital, Central South University, Changsha  410013, Hunan Province, China;
    2Department of Infection Diseases, Second Xiangya Hospital, Central South University, Changsha  410011, Hunan Province, China
  • Online:2010-03-05 Published:2010-03-05
  • Contact: Tang Xiao-peng, Doctor, Department of Infection Diseases, Second Xiangya Hospital, Central South University, Changsha 410011, Hunan Province, China Xiaopeng1959@163.com
  • About author:Chen Li-min, Master, Department of Infection Diseases, Third Xiangya Hospital, Central South University, Changsha 410013, Hunan Province, China zifanchen@yahoo. com.cn

PDF

492

Abstract:

BACKGROUND: Umbilical cord blood transplantation can ameliorate hepatic and immunologic function, repair hepatic injury, and promote hepatic regeneration, however, the differentiation mechanism and biological characteristics remain poorly understood, and the long-term efficiency need to be explored.  

OBJECTIVE: To investigate the long-term therapeutic efficacy of infusing umbilical cord blood and blood plasma in treating chronic severe hepatitis B patients.

METHODS: Totally 50 chronic severe hepatitis B patients received treatment at the Second Xiangya Hospital, Central South University from January 2003 to January 2004 were randomly divided into the treatment and control groups, with 25 cases in each group. All patient were accepted an ordinary synthetic treatment, and the differences between age, pathogenetic condition, medication had no significance. The umbilical cord blood was obtained from healthy full-term spontaneous delivery parturient, centrifugated, remained karyotes and cord plasma, and used within 24 hours. Patients in the treatment group were received umbilical cord blood infusion, 200 mL once, 1-2 times per week, totally, each patients infused 4-8 times (mean 5 times); those in the control group were infused with adult fresh blood plasma. The changes of hemogram and hepatic function were measured. 

RESULTS AND CONCLUSION: All the patients were followed-up for 1 year. The hemogram and hepatic function indexes were similar in the 2 groups before treatment (P > 0.05). The hemogram index had no obviously difference at 1 year after treatment (P > 0.05), but the alanine aminotransferase and total bilirubin levels were decreased in the treatment compared with the control group (P < 0.05), but the albumin was significantly increased (P < 0.05). Compared with before treatment, the platelet level had no significant changes at 1 year after treatment, but the alanine aminotransferase and total bilirubin levels were deeply decreased (P < 0.05), albumin was significantly increased (P < 0.05); the platelet and albumin levels were dramatically decreased in the control group (P < 0.05). It suggested that umbilical cord blood infusion can improve the hepatic function and hemogram; therefore, it can be served as supplementary therapeutic measure for severe hepatitis.

CLC Number: